Kamal Adawi is Secretary at EXAGEN INC. (XGN). They have made 5 open-market trades across 2 companies since 2023, most recently 2026-11-03.
CIK 0001788393
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 5 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| XGN | 247,236 | $2.1M |
| FATE | 93,418 | $196K |
| Total | $2.3M |
Shares reported on the most recent Form 4, priced at the 2026-11-04 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FATE | SELL | 2026-11-03 | 2026-11-04 | $2.05 | $14K | — | — | — |
| XGN | SELL | 2024-03-04 | 2024-03-06 | $1.91 | $24K | -9.2% | -23.1% | +0.5% |
| XGN | SELL | 2024-02-06 | 2024-02-08 | $1.95 | $13K | +2.0% | -6.6% | -29.3% |
| XGN | SELL | 2023-03-02 | 2023-03-03 | $2.30 | $8K | -2.1% | -1.2% | +30.2% |
| XGN | SELL | 2023-02-08 | 2023-02-10 | $2.69 | $16K | +5.1% | -7.4% | +12.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.